[Improvement of I-PCR and its application in gene diagnosis of hemophilia A].

Zhonghua Xue Ye Xue Za Zhi

Department of Medical Genetics, Medical School, Sun Yat-Sen University, Guangzhou 510080, China.

Published: May 2009

Objective: To improve inversion-polymerase chain reaction (I-PCR) in detection of factor VIII (FVIII) intron 22 inversion for gene diagnosis and prenatal diagnosis of hemophilia A (HA).

Methods: The modified I-PCR was applied to detect FVIII intron 22 inversion in 8 families with HA. The prenatal diagnosis was performed for 2 pregnant women in the families. The fetal blood samples were obtained by cordocentesis at 22 and 26 weeks gestation respectively.

Results: Four of 8 HA families were diagnosed to be FVIII intron 22 inversion. Two fetuses were identified to be normal and one of them was born normal.

Conclusion: The modified I-PCR enables the gene diagnosis and prenatal diagnosis of FVIII intron 22 inversion more accurately and rapidly.

Download full-text PDF

Source

Publication Analysis

Top Keywords

fviii intron
16
intron inversion
16
gene diagnosis
12
prenatal diagnosis
12
diagnosis hemophilia
8
diagnosis prenatal
8
modified i-pcr
8
diagnosis
6
[improvement i-pcr
4
i-pcr application
4

Similar Publications

Objectives: Hemophilia A (HA) is an X-linked recessive inherited bleeding disorder that typically affects men. Women are usually asymptomatic carriers, and rarely presenting with severe or moderately severe phenotype. This study aims to describe a case of a 17-year-old girl with moderate HA, investigating the mechanisms of her condition and the genetic basis within her family.

View Article and Find Full Text PDF

Hemophilia A (HA) is an inherited condition that is characterized by a lack of coagulation factor VIII (FVIII), which is needed for blood clotting. To produce recombinant factor VIII (rFVIII) for treatment, innovative methods are required. This study presents a thorough examination of the genetic engineering and biotechnological methods that are essential for the production of this complex process.

View Article and Find Full Text PDF

Hemophilia A (HA) is an X-chromosome-linked recessive genetic disorder. Female carriers may have bleeding symptoms, but rarely have moderate or severe disease. We identified a female patient with moderate HA by pedigree tracking and genetic testing in a HA family involving consanguineous marriage.

View Article and Find Full Text PDF

Genetic Diagnosis and Prenatal Diagnosis of a Rare FVIII Family With Haemophilia A.

J Cell Mol Med

December 2024

Reproductive Genetics Department, Hebei General Hospital, Shijiazhuang, Hebei, China.

Article Synopsis
  • - The study focused on identifying genetic variations causing haemophilia A within a unique family, using advanced techniques like DHPLC and PCR for diagnosis.
  • - Comprehensive clinical data and laboratory tests revealed the proband's significantly prolonged activated partial prothrombin time (APTT) and low clotting factor VIII activity, suggesting serious coagulation issues.
  • - A rare pathogenic mutation involving a 226 bp insertion in the F8 gene was discovered, highlighting the importance of using multiple experimental approaches for effective genetic diagnosis of haemophilia A.
View Article and Find Full Text PDF
Article Synopsis
  • Haemophilia A (HA) is a rare bleeding disorder linked to mutations in the F8 gene, with unclear causes in some patients, particularly among females with severe forms.
  • The study aimed to explore the genetic defects causing severe HA in two specific patients and offer personalized reproductive options for their families.
  • Advanced sequencing techniques unveiled unique mutations in both patients, leading to successful reproductive interventions, including preimplantation genetic testing and prenatal diagnosis to prevent passing on the disorder.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!